| Identification | Back Directory | [Name]
2,4-Difluoro-5-{5H,6H,7H,8H,9H-[1,2,4]triazolo[4,3-a]azepin-3-yl}aniline | [CAS]
941166-01-4 | [Synonyms]
2,4-Difluoro-5-{5H,6H,7H,8H,9H-[1,2,4]triazolo[4,3-a]azepin-3-yl}aniline
Benzenamine, 2,4-difluoro-5-(6,7,8,9-tetrahydro-5H-1,2,4-triazolo[4,3-a]azepin-3-yl)- | [Molecular Formula]
C13H14F2N4 | [MDL Number]
MFCD09403621 | [MOL File]
941166-01-4.mol | [Molecular Weight]
264.27 |
| Chemical Properties | Back Directory | [Melting point ]
222-223°C | [Boiling point ]
466.6±55.0 °C(Predicted) | [density ]
1.47±0.1 g/cm3(Predicted) | [storage temp. ]
-20°C Freezer, Under inert atmosphere | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
2.19±0.10(Predicted) | [color ]
Light Orange to Light Brown |
| Hazard Information | Back Directory | [Uses]
2,4-Difluoro-5-{5H,6H,7H,8H,9H-[1,2,4]triazolo[4,3-a]azepin-3-yl}aniline is a derivative of 3-(3,4-Dichlorophenyl)-6,7,8,9-tetrahydro-5H-1,2,4-triazolo[4,3-a]azepine (CAS# 400082-60-2), which has therapeutic applications in treatment of metabolic syndrome and is a hydroxysteroid dehydrogenase inhibitor-antihypertensive agent. |
|
|